HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal Vows Faster Action On Global Trends To Counter Local Brands

This article was originally published in The Rose Sheet

Executive Summary

Local, on-trend brands were the biggest winners in mass markets around the world in 2015, according to L'Oreal leadership, but the firm's Consumer Products Division is working to identify and pounce on global trends faster. In addition, the division is committed to repositioning its core brands, innovating "more than ever" and enhancing its digital activities in order to grow ahead of the market in 2016.

You may also be interested in...



Prestige, Color Cosmetics Shine In Beauty Big-Leaguers' Q2 Earnings

The Estee Lauder Companies' namesake brand and Clinique unit are emphasizing makeup after years of focusing on skin care, illustrating the firm's ready capacity to shift directions and resources as consumer interests change. Lauder's strategic investments paid off in the second quarter, and Coty is hoping to see similar rewards as it builds the higher end of its portfolio and integrates newly acquired beauty brands.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS020012

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel